If you’re a member of the media working on a story about brain trauma or brain health, we can connect you with the experts at Cohen Veterans Bioscience. Please don’t hesitate to contact us.
Senior Director, Communications
Cohen Veterans Bioscience
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
Follow Cohen Veterans Bioscience
CDISC and Cohen Veterans Bioscience Announce Release of First Data Standard to Improve Research for Post Traumatic Stress DisorderRead more
CDISC and Cohen Veterans Bioscience are pleased to announce the publication of a new Therapeutic Area (TA) Standard for Post Traumatic Stress Disorder released in the form of a User Guide for data managers, statisticians, programmers and study managers.
The Michael J. Fox Foundation Partners with Cohen Veterans Bioscience on BRAIN Commons, Harnessing the Power of Big Data for Brain DiseasesRead more
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Cohen Veterans Bioscience announce their partnership on BRAIN Commons, a platform designed to fuel the use of big data in brain disease research. It provides unprecedented access to research data and analytics.
Cohen Veterans Bioscience Receives Research Award from Department of Defense’s Medical Research and Materiel Command to Establish A Clinical Trial Infrastructure and Conduct an Adaptive Platform Trial Testing Post-Traumatic Stress Disorder (PTSD) PharmacotherapeuticsRead more
Cohen Veterans Bioscience will establish a clinical trial infrastructure and serve as the Clinical Coordinating Center for a 3.5-year study to comparatively test pharmacotherapeutics for PTSD.
- Read more
Early Signal subsidiary will expand CVB’s role as a hub for translational research and data analytics to fast-track solutions for brain disorders
Brainsway and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress DisorderRead more
Brainsway, a leader in the advanced non-invasive treatment of brain disorders, and Cohen Veterans Bioscience today announced the launch of a new research collaboration with the Stanford University School of Medicine to identify potential biomarkers in patients suffering from Post Traumatic Stress Disorder (PTSD).